Menopause is marked by declining estrogen and progesterone, causing hot flashes, sleep disruption, mood changes, vaginal dryness, and accelerated bone loss. Hormone replacement therapy (HRT/MHT) remains the most effective treatment for symptoms and bone protection in eligible women. Always rule out thyroid disease, which mimics many menopausal symptoms.
Menopause is a natural biological transition, not a disease — but its hormonal changes have wide-reaching effects on bone health, metabolic health, cardiovascular health, and quality of life. Understanding what is happening hormonally helps guide treatment decisions.
The Hormonal Transition
- Perimenopause (typically 40s–early 50s): Estrogen levels fluctuate erratically — sometimes very high, sometimes very low — causing irregular periods and variable symptoms. FSH rises. Can last 4–10 years.
- Menopause: Defined as 12 consecutive months without a menstrual period. Average age in the US is 51.
- Postmenopause: Estrogen and progesterone persistently low; FSH elevated; gradual testosterone decline continues.
Symptoms
- Vasomotor symptoms (hot flashes / night sweats): Affect ~75% of women; result from estrogen-depletion causing dysregulation of the brain's temperature control center (hypothalamus)
- Sleep disturbances — often driven by night sweats
- Mood changes: irritability, anxiety, depression — more common in perimenopause with fluctuating estrogen
- Cognitive symptoms: brain fog, difficulty concentrating
- Genitourinary syndrome (GSM): vaginal dryness, painful intercourse, urinary urgency, recurrent UTIs
- Decreased libido
- Joint aches and muscle changes
- Accelerated bone loss (see below)
🦋 Always Check Thyroid First: Hypothyroidism shares many symptoms with menopause — fatigue, weight gain, mood changes, brain fog, menstrual irregularities. Every woman presenting with menopausal symptoms should have a TSH measured. These conditions commonly coexist and both require treatment.
Effects on Bone Health
Estrogen protects bone by suppressing bone resorption. After menopause, bone loss accelerates to 1–3% per year for the first 3–5 years — compared to ~0.5% per year before menopause. Women can lose up to 20% of bone density in the first decade after menopause. DEXA bone density screening is recommended at age 65 (or earlier with risk factors) — ask your endocrinologist.
Effects on Metabolic Health
- Shift to central (abdominal) fat distribution → increased insulin resistance
- Higher risk of type 2 diabetes after menopause
- Adverse changes in cholesterol: LDL rises, HDL decreases
- Blood pressure tends to increase
Hormone Replacement Therapy (HRT / MHT)
Menopausal hormone therapy remains the most effective treatment for vasomotor symptoms, GSM, and bone protection. Modern reassessment of the WHI data shows the risks are low for healthy women under 60 or within 10 years of menopause.
| Symptom | HRT Benefit |
|---|---|
| Hot flashes / night sweats | Most effective treatment — 75–90% reduction |
| Vaginal dryness / GSM | Local vaginal estrogen highly effective with minimal systemic absorption |
| Bone loss | Prevents bone loss and reduces fracture risk |
| Sleep and mood | Improvement in many women, especially in early menopause |
Contraindications to systemic HRT: Personal history of breast cancer, endometrial cancer, blood clots (DVT/PE), stroke, or uncontrolled cardiovascular disease. Discuss risks and benefits with your provider.
Non-Hormonal Options for Hot Flashes
- Fezolinetant (Veozah): FDA-approved; targets the brain's neurokinin 3 receptor pathway — addresses the root cause of hot flashes without hormones
- Venlafaxine (Effexor) or paroxetine (Brisdelle): SSNRIs/SSRIs with evidence for hot flash reduction
- Gabapentin: Particularly helpful for nighttime hot flashes
- Lifestyle: cool environment, layered clothing, avoid triggers (alcohol, caffeine, spicy food)
Key Takeaways
- Menopause = 12 months without a period; driven by declining estrogen and progesterone
- Always check TSH — thyroid disease mimics many menopausal symptoms and both can coexist
- Hot flashes, sleep disruption, vaginal dryness, mood changes, and bone loss are the main concerns
- Bone loss accelerates 1–3%/year for first 3–5 years after menopause — DEXA screening is important
- HRT/MHT is safe and highly effective for eligible women under 60 or within 10 years of menopause
- Local vaginal estrogen for GSM has minimal systemic absorption and is safe even for many women who can't take systemic HRT
- Non-hormonal options: fezolinetant (Veozah), venlafaxine, gabapentin
Our Team Can Help
Book an Appointment or call 832-968-7003